(Q50620349)

English

Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prévention Secondaire de l'Infarctus.

scientific article published in March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prévention Secondaire de l'Infarctus. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Cucherat M

1

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

Boissel JP

2

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

Leizorovicz A

3

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

language of work or name

0 references

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

79

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

5

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

587-589

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900820-X

7 January 2021

Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900820-X

7 January 2021

A long-term prevention study with oxprenolol in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900820-X

7 January 2021

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900820-X

7 January 2021

Efficacy of acebutolol after acute myocardial infarction (the APSI trial). The APSI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900820-X

7 January 2021

Identifiers

10.1016/S0002-9149(96)00820-X

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9068513

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50620349&oldid=2186618601"